Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.84 USD
+0.33 (3.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $9.88 +0.04 (0.41%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.84 USD
+0.33 (3.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $9.88 +0.04 (0.41%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Zacks News
Teladoc (TDOC) Stock Moves -1.57%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $19.43, marking a -1.57% move from the previous day.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) concluded the recent trading session at $20.35, signifying a +0.79% move from its prior day's close.
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Teladoc (TDOC) reachead $20.24 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Teladoc (TDOC) concluded the recent trading session at $21.80, signifying a -0.05% move from its prior day's close.
Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Teladoc (TDOC) concluded the recent trading session at $21.36, signifying a +0.56% move from its prior day's close.
Here's Why You Should Retain Teladoc (TDOC) Stock for Now
by Zacks Equity Research
Teladoc's (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
Why Is Teladoc (TDOC) Down 2.1% Since Last Earnings Report?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health (TDOC) Q3 Loss Narrows on Integrated Care Strength
by Zacks Equity Research
Teladoc Health's (TDOC) Q3 results were aided by membership growth in the Integrated Care unit as well as strong BetterHelp revenues. Management presently expects 2023 net loss per share to be within $1.50-$1.40.
Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teladoc (TDOC) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 5.41% and 0.37%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 8.82% and 3.41%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Growing Visits Aid Teladoc's (TDOC) Earnings in Q3?
by Zacks Equity Research
Teladoc's (TDOC) third-quarter results are likely to reflect growth in BetterHelp paying users.
Why the Market Dipped But Teladoc (TDOC) Gained Today
by Zacks Equity Research
Teladoc (TDOC) concluded the recent trading session at $19.19, signifying a +1.43% move from its prior day's close.
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
The latest trading day saw Teladoc (TDOC) settling at $18.64, representing a -0.32% change from its previous close.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $18.43, moving -0.86% from the previous trading session.
Here's Why Hold Strategy is Apt for Teladoc (TDOC) Stock Now
by Zacks Equity Research
Teladoc's (TDOC) BetterHelp business is expected to gain from new member growth and stable customer acquisition costs.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $19.07, marking a +1.54% move from the previous day.
Teladoc (TDOC) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $20.75 in the latest trading session, marking a -0.1% move from the prior day.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $22.46, marking a -1.45% move from the previous day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $22.97 in the latest trading session, marking a +0.31% move from the prior day.
Teladoc (TDOC) Stock Moves -0.09%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $22.64, marking a -0.09% move from the previous day.
Teladoc (TDOC) Down 20.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health (TDOC) Q2 Earnings Top Estimates on Lower Expenses
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 results reflect improving access fees and other revenues coupled with lower expenses.
Compared to Estimates, Teladoc (TDOC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 9.09% and 0.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?